2024 / 01

Next Paper
DOI: 10.47183/mes.2024.002
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

REVIEW

Molecular genetic studies in the context of biomedical risks for cosmonauts' health

Latartsev KV1,2, Kaspranskiy RR1,2
About authors

1 Federal State Budgetary Institution “Federal Research and Clinic Center of Space Medicine” of the Federal Biomedical Agency, Moscow, Russia

2 Lomonosov Moscow State University, Moscow, Russia

Correspondence should be addressed: Konstantin V. Latartsev
Shchukinskaya, 5, str. 2, Moscow, 123182, Russia, moc.liamg@vestratal.k

About paper

Funding: the study was supported by the RSF grant (project № 22-25-20145 “Exploring the Mechanisms Underlying the Effects of Tolerance to Food Antigens on the Glucose Utilization”.

Author contributions: Latartsev KV — search and analysis of sources, article authoring, editing; Kaspranskiy RR — concept development, article editing.

Received: 2023-11-16 Accepted: 2023-12-20 Published online: 2024-03-04
|
  1. Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Human Psychopharmacology: Clinical and Experimental. 2008; 23 (7): 571–85.
  2. Johansson C, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology. 2003; 28 (4): 734–9.
  3. Gotlib IH, et al. HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biological psychiatry. 2008; 63 (9): 847–51.
  4. Laje G, et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. American Journal of Psychiatry. 2007; 164 (10): 1530–8.
  5. Hejjas K, et al. Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2009; 150 (2): 295–9.
  6. Teper E, O'Brien JT. Vascular factors and depression. International Journal of Geriatric Psychiatry: A journal of the psychiatry of late life and allied sciences. 2008; 23 (10): 993–1000.
  7. Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Human Psychopharmacology: Clinical and Experimental. 2008; 23 (7): 571–85.
  8. Johansson C, et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology. 2003; 28 (4): 734–9.
  9. Goel N, Dinges DF. Predicting risk in space: genetic markers for differential vulnerability to sleep restriction. Acta astronautica. 2012; 77: 207–13.
  10. Goel N, et al. Circadian rhythms, sleep deprivation, and human performance. Progress in molecular biology and translational science. 2013; 119: 155–90.
  11. Dickinson D, Elvevåg B. Genes, cognition and brain through a COMT lens. Neuroscience. 2009; 164 (1): 72–87.
  12. Gaedigk A. Complexities of CYP2D6 gene analysis and interpretation. International review of psychiatry. 2013; 25 (5): 534–53.
  13. Rudberg I, et al. Impact of the ultrarapid CYP2C19* 17 allele on serum concentration of escitalopram in psychiatric patients. Clinical Pharmacology & Therapeutics. 2008; 83 (2): 322–7.
  14. Werk AN, Cascorbi I. Functional gene variants of CYP3A. Clinical Pharmacology & Therapeutics. 2014; 96 (3): 340–8.
  15. Lee KC, Ma JD, Kuo GM. Pharmacogenomics: bridging the gap between science and practice. Journal of the American Pharmacists Association. 2010; 50 (1): e1-e17.
  16. Lee SH, et al. Association between the 5‐HT6 receptor C267T polymorphism and response to antidepressant treatment in major depressive disorder. Psychiatry and clinical neurosciences. 2005; 59 (2): 140–5.
  17. Helton SG, Lohoff FW. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders. Pharmacogenomics. 2015; 16 (5): 541–53.
  18. Vijaya Lakshmi SV, et al. Oxidative stress is associated with genetic polymorphisms in one-carbon metabolism in coronary artery disease. Cell biochemistry and biophysics. 2013; 67: 353–61.
  19. Lin H, et al. Gene-gene interaction analyses for atrial fibrillation. Scientific reports. 2016; 6 (1): 35371.
  20. Eisenberg DTA, Kuzawa CW, Hayes MG. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history.American journal of physical anthropology. 2010; 143 (1): 100–11.
  21. Zwart SR, et al. Genotype, B-vitamin status, and androgens affect spaceflight-induced ophthalmic changes. The FASEB Journal. 2016; 30 (1): 141.
  22. Glueck CJ, et al. Idiopathic intracranial hypertension, polycysticovary syndrome, and thrombophilia. Journal of Laboratory and Clinical Medicine. 2005; 145 (2): 72–82.
  23. Thompson D, et al. Cancer risks and mortality in heterozygous ATM mutation carriers. Journal of the National Cancer Institute. 2005; 97 (11): 813–22.
  24. Yang M, et al. Association of hsp70 polymorphisms with risk of noise-induced hearing loss in Chinese automobile workers. Cell stress & chaperones. 2006; 11 (3): 233.
  25. Konings A, et al. Variations in HSP70 genes associated with noiseinduced hearing loss in two independent populations. European Journal of Human Genetics. 2009; 17 (3): 329–35.
  26. Villasana L, et al. Passive avoidance learning and memory of 56Fe sham-irradiated and irradiated human apoE transgenic mice. Radiatsionnaia Biologiia, Radioecologiia. 2008; 48 (2): 167–70.
  27. Liu CC, et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nature Reviews Neurology. 2013; 9 (2): 106–18.
  28. Utkin KV, et al. Ustanovlenie geneticheskikh markerov ustoychivosti i chuvstvitel'nosti cheloveka k radiatsionnomu vozdeystviyu. Immunologiya. 2013; 34 (2): 80–4. Russian.
  29. Yuan J, et al. Advanced genetic approaches in discovery and characterization of genes involved with osteoporosis in mouse and human. Frontiers in Genetics. 2019; 10: 288.
  30. Tan LJ, et al. Molecular genetic studies of gene identification for sarcopenia. Human genetics. 2012; 131: 1–31.
  31. Ralston SH, Uitterlinden AG. Genetics of osteoporosis. Endocrine reviews. 2010; 31 (5): 629–62.
  32. Judex S, et al. Genetic loci that control the loss and regain of trabecular bone during unloading and reambulation. Journal of Bone and Mineral Research. 2013; 28 (7): 1537–49.
  33. Shammas MA. Telomeres, lifestyle, cancer, and aging. Current opinion in clinical nutrition and metabolic care. 2011; 14 (1): 28.
  34. Cawthon RM, et al. Association between telomere length in blood and mortality in people aged 60 years or older. The Lancet. 2003; 361 (9355): 393–5.
  35. Wu X, et al. Telomere dysfunction: a potential cancer predisposition factor. Journal of the national cancer institute. 2003; 95 (16): 1211–8.
  36. Epel ES, et al. Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences. 2004; 101 (49): 17312–5.
  37. Ayouaz A, et al. Telomeres: hallmarks of radiosensitivity. Biochimie. 2008; 90 (1): 60–72.
  38. Grigorev K, et al. Haplotype diversity and sequence heterogeneity of human telomeres. Genome research. 2021; 31 (7): 1269–79.
  39. Luxton JJ, et al. Telomere length dynamics and DNA damage responses associated with long-duration spaceflight. Cell Reports. 2020; 33 (10).
  40. Nishi H, et al. Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Molecular and cellular biology. 2004; 24 (13): 6076–83.
  41. Bezdan D, et al. Cell-free DNA (cfDNA) and exosome profiling from a year-long human spaceflight reveals circulating biomarkers. Iscience. 2020; 23 (12).
  42. Snyder MW, et al. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell. 2016; 164 (1): 57–68.
  43. Yoshioka Y, et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nature communications. 2014; 5 (1): 3591.
  44. Hoshino A, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015; 527 (7578): 329–35.
  45. Kumar Deshmukh F, et al. The contribution of the 20S proteasome to proteostasis. Biomolecules. 2019; 9 (5): 190.
  46. Kudriaeva AA, Belogurov AA. Proteasome: a Nanomachinery of Creative Destruction. Biochemistry. 2019; 84: 159–92. Russian.
  47. Alvarez R, et al. A simulated microgravity environment causes a sustained defect in epithelial barrier function. Scientific reports. 2019; 9 (1): 17531.
  48. Mencia-Trinchant N, et al. Clonal hematopoiesis before, during, and after human spaceflight. Cell reports. 2020; 33 (10).
  49. Genovese G, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. New England Journal of Medicine. 2014; 371 (26): 2477–87.
  50. Pastushkova LKh, et al. Changes in blood proteome of cosmonauts with microand macrovascular injuries due to g-loads at the final stage of long-duration space missions. Aviakosmicheskaya i Ekologicheskaya Meditsina. 2020; 54 (5): 5–14. Russian.
  51. Kashirina DN, et al. Changes in the Plasma Protein Composition in Astronauts after Space Flight and its Significance for Endothelial Functions. Human Physiology. 2019; 45 (1): 88–96. Russian.
  52. Morukov VB, et al. Indicators of innate and adaptive immunity of cosmonauts after long-term space flight to international space station. Human Physiology. 2010; 36 (3): 19–30. Russian.
  53. Rykova MP. Immune system in Russian cosmonauts after orbital space flights. Human Physiology. 2013; 39 (5): 126–126. Russian.
  54. Novikov VE, et al. Mineral'naya plotnost' kostnoy tkani i molekulyarno-geneticheskie markery ee remodelirovaniya v krovi u kosmonavtov posle dlitel'nykh poletov na mezhdunarodnoy kosmicheskoy stantsii. Human Physiology. 2017; 43 (6): 88–94. Russian.
  55. Sapetsky AO, et al. Radiation neurobiology of long-term space flights. Biology Bulletin Reviews. 2017; 137 (2): 165–94. Russian.